 Itraconazole opportunistic mycoses cryptococcosis aspergillosis results oral itraconazole therapy opportunistic mycoses patients cryptococcal meningitis complete responses patients acquired immunodeficiency syndrome Other manifestations cryptococcosis responsive aspergillosis patients immunocompromised hosts patients invasive pulmonary disease skeletal disease pleural disease pericardial sinus mastoid hepatosplenic nail disease results itraconazole compare conventional parenteral therapy toxicity minimal comparative trials order